Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Trifocal IOL implantation for the correction of presbyopia in cataract patients: 4-year experience

Poster Details

First Author: M.Piovella ITALY

Co Author(s):    B. Kusa                    

Abstract Details

Purpose:

To evaluate visual and optical performances of cataract eyes after phacoemulsification and trifocal IOL implantation(AT LISA tri 839 MP). Evaluation of a new method to improve visual outcomes based on eye selection and not on patients habits.

Setting:

C.M.A. Centro Microchirurgia Ambulatoriale Monza �â�€�“ Italy

Methods:

118 eyes of 73 patients (mean age: 67.87 �Â�± 11.49 year) underwent uncomplicated phacoemulsification and trifocal IOL implantation. Preloaded IOL was implanted using an injector for a 2.4 corneal incision. Pre- and postoperatively, the following visual and refractive parameters were measured: distance (5m) near (40cm) and intermediate (80 cm) visual acuity, corneal topography and aberrometry, contrast sensitivity and defocus curve. Regular follow-up examinations were performed up to 4 years after surgery.

Results:

Preoperative distance UCVA was 20/112. At 4 years, distance UCVA was 20/20 , monocular and binocular uncorrected near vision and intermediate vision were 20/32. After four year experience with trifocal technology, in 2015 we implanted these trifocal IOLs in 73% of cataract. 94% of eyes achieved postoperative refractive results within �Â�± 0.50 diopters from plano

Conclusions:

Trifocal IOL provided good distance and near as well as intermediate visual acuity. This lens provides superior quality of vision. Eyes and IOLs power selection adopting best advanced technology and an improved organization are the most important key points to get successful results

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing